Selected research
Industry Research
Bio Implant Allograft & Xenograft Industry Research Report 2026
Market perspective
The global Bio Implant Allograft & Xenograft market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bio Implant Allograft & Xenograft market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bio Implant Allograft & Xenograft market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bio Implant Allograft & Xenograft market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bio Implant Allograft & Xenograft include Medtronic, Zimmer Biomet, Xtant Medical, Wright Medical, Straumann, OneGraft® Gmbh, Geistlich, DePuy and Collagen Matrix, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bio Implant Allograft & Xenograft market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bio Implant Allograft & Xenograft.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bio Implant Allograft & Xenograft Market by Company
Medtronic
Zimmer Biomet
Xtant Medical
Wright Medical
Straumann
OneGraft® Gmbh
Geistlich
DePuy
Collagen Matrix
Citagenix Inc
Arthrex
Bio Implant Allograft & Xenograft Segment by Type
Allografts
Xenografts
Bio Implant Allograft & Xenograft Segment by Application
Spinal Fusion
Bone Trauma
Others
Bio Implant Allograft & Xenograft Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio Implant Allograft & Xenograft market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bio Implant Allograft & Xenograft and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio Implant Allograft & Xenograft.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bio Implant Allograft & Xenograft companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Allografts
- Xenografts
Applications
- Spinal Fusion
- Bone Trauma
- Others
Companies covered
- Medtronic
- Zimmer Biomet
- Xtant Medical
- Wright Medical
- Straumann
- OneGraft® Gmbh
- Geistlich
- DePuy
- Collagen Matrix
- Citagenix Inc
- Arthrex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bio Implant Allograft & Xenograft by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Allografts
- 2.2.3 Xenografts
- 2.3 Bio Implant Allograft & Xenograft by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Spinal Fusion
- 2.3.3 Bone Trauma
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Bio Implant Allograft & Xenograft Breakdown Data by Type
- 3.1 Global Bio Implant Allograft & Xenograft Historic Market Size by Type (2021-2026)
- 3.2 Global Bio Implant Allograft & Xenograft Forecasted Market Size by Type (2027-2032)
4 Bio Implant Allograft & Xenograft Breakdown Data by Application
- 4.1 Global Bio Implant Allograft & Xenograft Historic Market Size by Application (2021-2026)
- 4.2 Global Bio Implant Allograft & Xenograft Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bio Implant Allograft & Xenograft Market Perspective (2021-2032)
- 5.2 Global Bio Implant Allograft & Xenograft Growth Trends by Region
- 5.2.1 Global Bio Implant Allograft & Xenograft Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bio Implant Allograft & Xenograft Historic Market Size by Region (2021-2026)
- 5.2.3 Bio Implant Allograft & Xenograft Forecasted Market Size by Region (2027-2032)
- 5.3 Bio Implant Allograft & Xenograft Market Dynamics
- 5.3.1 Bio Implant Allograft & Xenograft Industry Trends
- 5.3.2 Bio Implant Allograft & Xenograft Market Drivers
- 5.3.3 Bio Implant Allograft & Xenograft Market Challenges
- 5.3.4 Bio Implant Allograft & Xenograft Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bio Implant Allograft & Xenograft Players by Revenue
- 6.1.1 Global Top Bio Implant Allograft & Xenograft Players by Revenue (2021-2026)
- 6.1.2 Global Bio Implant Allograft & Xenograft Revenue Market Share by Players (2021-2026)
- 6.2 Global Bio Implant Allograft & Xenograft Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bio Implant Allograft & Xenograft Head Office and Area Served
- 6.4 Global Bio Implant Allograft & Xenograft Players, Product Type & Application
- 6.5 Global Bio Implant Allograft & Xenograft Manufacturers Established Date
- 6.6 Global Bio Implant Allograft & Xenograft Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bio Implant Allograft & Xenograft Market Size (2021-2032)
- 7.2 North America Bio Implant Allograft & Xenograft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bio Implant Allograft & Xenograft Market Size by Country (2021-2026)
- 7.4 North America Bio Implant Allograft & Xenograft Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bio Implant Allograft & Xenograft Market Size (2021-2032)
- 8.2 Europe Bio Implant Allograft & Xenograft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bio Implant Allograft & Xenograft Market Size by Country (2021-2026)
- 8.4 Europe Bio Implant Allograft & Xenograft Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bio Implant Allograft & Xenograft Market Size (2021-2032)
- 9.2 Asia-Pacific Bio Implant Allograft & Xenograft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bio Implant Allograft & Xenograft Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bio Implant Allograft & Xenograft Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bio Implant Allograft & Xenograft Market Size (2021-2032)
- 10.2 South America Bio Implant Allograft & Xenograft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bio Implant Allograft & Xenograft Market Size by Country (2021-2026)
- 10.4 South America Bio Implant Allograft & Xenograft Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bio Implant Allograft & Xenograft Market Size (2021-2032)
- 11.2 Middle East & Africa Bio Implant Allograft & Xenograft Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bio Implant Allograft & Xenograft Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bio Implant Allograft & Xenograft Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Medtronic
- 12.1.1 Medtronic Company Information
- 12.1.2 Medtronic Business Overview
- 12.1.3 Medtronic Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.1.4 Medtronic Bio Implant Allograft & Xenograft Product Portfolio
- 12.1.5 Medtronic Recent Developments
- 12.2 Zimmer Biomet
- 12.2.1 Zimmer Biomet Company Information
- 12.2.2 Zimmer Biomet Business Overview
- 12.2.3 Zimmer Biomet Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.2.4 Zimmer Biomet Bio Implant Allograft & Xenograft Product Portfolio
- 12.2.5 Zimmer Biomet Recent Developments
- 12.3 Xtant Medical
- 12.3.1 Xtant Medical Company Information
- 12.3.2 Xtant Medical Business Overview
- 12.3.3 Xtant Medical Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.3.4 Xtant Medical Bio Implant Allograft & Xenograft Product Portfolio
- 12.3.5 Xtant Medical Recent Developments
- 12.4 Wright Medical
- 12.4.1 Wright Medical Company Information
- 12.4.2 Wright Medical Business Overview
- 12.4.3 Wright Medical Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.4.4 Wright Medical Bio Implant Allograft & Xenograft Product Portfolio
- 12.4.5 Wright Medical Recent Developments
- 12.5 Straumann
- 12.5.1 Straumann Company Information
- 12.5.2 Straumann Business Overview
- 12.5.3 Straumann Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.5.4 Straumann Bio Implant Allograft & Xenograft Product Portfolio
- 12.5.5 Straumann Recent Developments
- 12.6 OneGraft® Gmbh
- 12.6.1 OneGraft® Gmbh Company Information
- 12.6.2 OneGraft® Gmbh Business Overview
- 12.6.3 OneGraft® Gmbh Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.6.4 OneGraft® Gmbh Bio Implant Allograft & Xenograft Product Portfolio
- 12.6.5 OneGraft® Gmbh Recent Developments
- 12.7 Geistlich
- 12.7.1 Geistlich Company Information
- 12.7.2 Geistlich Business Overview
- 12.7.3 Geistlich Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.7.4 Geistlich Bio Implant Allograft & Xenograft Product Portfolio
- 12.7.5 Geistlich Recent Developments
- 12.8 DePuy
- 12.8.1 DePuy Company Information
- 12.8.2 DePuy Business Overview
- 12.8.3 DePuy Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.8.4 DePuy Bio Implant Allograft & Xenograft Product Portfolio
- 12.8.5 DePuy Recent Developments
- 12.9 Collagen Matrix
- 12.9.1 Collagen Matrix Company Information
- 12.9.2 Collagen Matrix Business Overview
- 12.9.3 Collagen Matrix Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.9.4 Collagen Matrix Bio Implant Allograft & Xenograft Product Portfolio
- 12.9.5 Collagen Matrix Recent Developments
- 12.10 Citagenix Inc
- 12.10.1 Citagenix Inc Company Information
- 12.10.2 Citagenix Inc Business Overview
- 12.10.3 Citagenix Inc Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.10.4 Citagenix Inc Bio Implant Allograft & Xenograft Product Portfolio
- 12.10.5 Citagenix Inc Recent Developments
- 12.11 Arthrex
- 12.11.1 Arthrex Company Information
- 12.11.2 Arthrex Business Overview
- 12.11.3 Arthrex Revenue in Bio Implant Allograft & Xenograft Business (2021-2026)
- 12.11.4 Arthrex Bio Implant Allograft & Xenograft Product Portfolio
- 12.11.5 Arthrex Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst